Clearside Biomedical, Inc. (NASDAQ:CLSD) Receives $5.00 Average Target Price from Brokerages
Shares of Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Free Report) have received a consensus recommendation of “Buy” from the five brokerages that are covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a buy rating. The average 12 month target price among brokerages that have issued ratings on the stock in […]
Shares of Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Free Report) have received a consensus recommendation of “Buy” from the five brokerages that are covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a buy rating. The average 12 month target price among brokerages that have issued ratings on the stock in […]
